ATE251914T1 - Arginine silicate inositol komplex und dessen verwendung - Google Patents

Arginine silicate inositol komplex und dessen verwendung

Info

Publication number
ATE251914T1
ATE251914T1 AT98905010T AT98905010T ATE251914T1 AT E251914 T1 ATE251914 T1 AT E251914T1 AT 98905010 T AT98905010 T AT 98905010T AT 98905010 T AT98905010 T AT 98905010T AT E251914 T1 ATE251914 T1 AT E251914T1
Authority
AT
Austria
Prior art keywords
pct
arginine silicate
inositol complex
silicate inositol
sec
Prior art date
Application number
AT98905010T
Other languages
English (en)
Inventor
Mark Mccarty
Jan Zielinski
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 filed Critical Nutrition 21
Application granted granted Critical
Publication of ATE251914T1 publication Critical patent/ATE251914T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/04—Esters of silicic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98905010T 1997-02-12 1998-02-11 Arginine silicate inositol komplex und dessen verwendung ATE251914T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/799,784 US5707970A (en) 1997-02-12 1997-02-12 Arginine silicate complex and use thereof
PCT/US1998/002443 WO1998034647A1 (en) 1997-02-12 1998-02-11 Arginine silicate inositol complex and use thereof

Publications (1)

Publication Number Publication Date
ATE251914T1 true ATE251914T1 (de) 2003-11-15

Family

ID=25176739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98905010T ATE251914T1 (de) 1997-02-12 1998-02-11 Arginine silicate inositol komplex und dessen verwendung

Country Status (16)

Country Link
US (3) US5707970A (de)
EP (1) EP1007096B1 (de)
JP (1) JP2001512443A (de)
KR (1) KR20000070977A (de)
CN (1) CN1182873C (de)
AT (1) ATE251914T1 (de)
AU (1) AU722975B2 (de)
BR (1) BR9807675A (de)
CA (1) CA2279233A1 (de)
DE (1) DE69819016T2 (de)
DK (1) DK1007096T3 (de)
ES (1) ES2209112T3 (de)
HU (1) HUP0001998A3 (de)
IL (1) IL130925A0 (de)
PT (1) PT1007096E (de)
WO (1) WO1998034647A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
WO2002008175A2 (en) * 2000-07-24 2002-01-31 Nutrition 21, Inc. Arginine saccharate and use thereof
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
TWI300947B (en) * 2001-07-12 2008-09-11 Semiconductor Energy Lab Display device using electron source elements and method of driving same
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
AU2002360765C1 (en) * 2001-12-20 2009-06-11 Trivascular, Inc. Advanced endovascular graft
WO2004017913A2 (en) * 2002-08-22 2004-03-04 Nutrition 21, Inc. Arginine silicate inositol complex and use thereof
US6803456B1 (en) * 2003-08-13 2004-10-12 Rutherford Chemicals Llc Process for the production of arginine-silicate complex
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
JP4852033B2 (ja) * 2004-03-11 2012-01-11 トリバスキュラー インコーポレイテッド モジュール式血管内移植片
MX2007001760A (es) * 2004-08-12 2007-07-24 Quest Pharmaceutical Services Composiciones farmaceuticas para la distribucion de liberacion controlada de compuestos biologicamente activos.
US7919620B2 (en) * 2005-06-01 2011-04-05 Coral Biotech Kabushiki Kaisha Agent for suppressing blood pressure elevation
ITMI20060677A1 (it) * 2006-04-06 2007-10-07 Damor Farmaceutici Profarmaci dell'arginina ad elevata attivita'terapeutica
WO2008035816A1 (en) * 2006-09-21 2008-03-27 Toshiki Oguro Promoter of hard tissue regeneration
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
JP6152346B2 (ja) 2011-03-01 2017-06-21 ジェーディーエス セラピューティックス、エルエルシーＪＤＳ Ｔｈｅｒａｐｅｕｔｉｃｓ，ＬＬＣ 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
ES2797688T3 (es) * 2015-06-30 2020-12-03 Nutrition 21 Llc Arginina silicato inositol para mejorar la función cognitiva
WO2017009679A1 (en) 2015-07-13 2017-01-19 Otis Elevator Company Deterrent device inhibition key
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness
GB2568849B (en) 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
EP3873331A4 (de) 2018-11-02 2022-08-24 Nutrition 21, LLC Zusammensetzungen mit inositolstabilisierten argininsilikatkomplexen und inositol zur verbesserung der kognitiven funktion bei videospielern
IL294021A (en) 2019-12-16 2022-08-01 Nutrition 21 Llc Methods of production of arginine-silicate complexes
WO2023086567A1 (en) * 2021-11-12 2023-05-19 Nutrition21, LLC Compositions and methods for treating or preventing myopathy in poultry
CN118206406B (zh) * 2024-03-20 2025-08-15 山东农业大学 精氨酸硅酸盐肌醇络合物在提高作物果实品质中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4385052A (en) * 1981-07-20 1983-05-24 International Plant Research Institute, Inc. Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US5250569A (en) * 1991-04-22 1993-10-05 Godfrey Science & Design, Inc. Amino acid flavorings of aluminum astringent for oral use
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof

Also Published As

Publication number Publication date
PT1007096E (pt) 2004-03-31
DE69819016D1 (de) 2003-11-20
EP1007096B1 (de) 2003-10-15
JP2001512443A (ja) 2001-08-21
DK1007096T3 (da) 2003-12-01
KR20000070977A (ko) 2000-11-25
HUP0001998A2 (hu) 2000-10-28
US6344444B1 (en) 2002-02-05
AU722975B2 (en) 2000-08-17
WO1998034647A1 (en) 1998-08-13
US6156735A (en) 2000-12-05
AU6273798A (en) 1998-08-26
US5707970A (en) 1998-01-13
DE69819016T2 (de) 2004-04-29
ES2209112T3 (es) 2004-06-16
CA2279233A1 (en) 1998-08-13
HUP0001998A3 (en) 2002-01-28
BR9807675A (pt) 2000-02-15
CN1182873C (zh) 2005-01-05
CN1246801A (zh) 2000-03-08
IL130925A0 (en) 2001-01-28
EP1007096A1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
ATE251914T1 (de) Arginine silicate inositol komplex und dessen verwendung
FI972164A0 (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
HRP990167B1 (en) Sulphinic acid derivatives, method for producing them, and their use
DE69531457D1 (en) Sulfonamide
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE437393T1 (de) Verfahren und vorrichtung zur bereitstellung eines entkoppelten leistungsverwaltungszustands
DK1303632T3 (da) Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
PT888327E (pt) Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
WO2000038620A3 (en) A composition useful to treat periodontal disease
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
BR0204057A (pt) Processos para geração de terahertz
DE69526731D1 (en) Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate
PT751774E (pt) Derivados de dissulfureto de mercaptoacetilamida hipocolesterolemicos
AU3703795A (en) Chondrocyte cell-lines
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them
ATE293605T1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren
UA30393A (uk) Спосіб лікування коронарного атеросклерозу

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007096

Country of ref document: EP

REN Ceased due to non-payment of the annual fee